Chemoinformaics analysis of LAVANDULOL
Molecular Weight | 154.253 | nRot | 4 |
Heavy Atom Molecular Weight | 136.109 | nRig | 2 |
Exact Molecular Weight | 154.136 | nRing | 0 |
Solubility: LogS | -2.632 | nHRing | 0 |
Solubility: LogP | 3.125 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 29 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 29.5043 |
nHD | 1 | BPOL | 18.0577 |
QED | 0.617 |
Synth | 3.461 |
Natural Product Likeliness | 3.121 |
NR-PPAR-gamma | 0.003 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.001 |
Pgp-sub | 0.003 |
HIA | 0.004 |
CACO-2 | -4.302 |
MDCK | 0.0000131 |
BBB | 0.993 |
PPB | 0.74032 |
VDSS | 1.791 |
FU | 0.232581 |
CYP1A2-inh | 0.337 |
CYP1A2-sub | 0.314 |
CYP2c19-inh | 0.035 |
CYP2c19-sub | 0.827 |
CYP2c9-inh | 0.009 |
CYP2c9-sub | 0.452 |
CYP2d6-inh | 0.019 |
CYP2d6-sub | 0.452 |
CYP3a4-inh | 0.019 |
CYP3a4-sub | 0.258 |
CL | 13.247 |
T12 | 0.504 |
hERG | 0.016 |
Ames | 0.006 |
ROA | 0.015 |
SkinSen | 0.125 |
Carcinogencity | 0.423 |
EI | 0.98 |
Respiratory | 0.201 |
NR-Aromatase | 0.005 |
Antiviral | No |
Prediction | 0.94598 |